Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Exosomes derived from cardiac progenitor cells attenuate CVB3-induced apoptosis via abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways.

Identifieur interne : 000343 ( Main/Exploration ); précédent : 000342; suivant : 000344

Exosomes derived from cardiac progenitor cells attenuate CVB3-induced apoptosis via abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways.

Auteurs : Xin Li [République populaire de Chine] ; Zuocheng Yang [République populaire de Chine] ; Wenyuan Nie [République populaire de Chine] ; Jie Jiang [République populaire de Chine] ; Shentang Li [République populaire de Chine] ; Zhuoying Li [République populaire de Chine] ; Lang Tian [République populaire de Chine] ; Xing Ma [République populaire de Chine]

Source :

RBID : pubmed:31534118

Descripteurs français

English descriptors

Abstract

Viral myocarditis is potentially fatal and lacking a specific treatment. Exosomes secreted by cardiac progenitor cells (CPCs) have emerged as a promising tool for cardioprotection and repair. In this study, we investigated whether CPCs-derived exosomes (CPCs-Ex) could utilize the mTOR signal pathway to reduce the apoptosis in viral myocarditis. In vitro, exosomes were, respectively, added to H9C2 cells after CVB3 infection to detect the anti-apoptosis effect of CPCs-Ex. Compared with the controls, the apoptosis rate was reduced, accompanied with the depressed expression of viral capsid protein 1 (VP1) and pro-apoptosis factors of Bim/caspase families. Meanwhile, the phosphorylation of Akt, mTOR, and p70S6K were promoted, but that of 4EBP1 was suppressed. In vivo, the results of apoptosis, expression of CVB3 and pro-apoptosis factors, and phosphorylation of Akt/mTOR factors of CVB3-infected cardiomyocytes were consistent with that of vitro. Following that, we use Rapamycin and MK-2206 to inhibit the Akt/mTOR signaling pathway, meanwhile, Rattus 4EBP1, p70S6K, Akt1 and Akt2 were transfected to H9C2 cells to establish the stably transfected cell lines. In the group with Rapamycin or MK-2206 pretreatment, CPCs-Ex also could decrease the apoptosis of H9C2 cells and expression of CVB3 mRNA, followed by decreased expression of apoptosis factors. In Akt2, p70S6K and 4EBP1 overexpression groups, CPCs-Ex promoted CVB3-induced apoptosis, VP1 expression and cleavage of caspase-3. Our results therefore identify CPCs-Ex exerts an anti-apoptosis effect in CVB3-infected cells by abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways as well as the expression of Bcl-2 and caspase families. Viral myocarditis, mainly caused by CVB3 infection, is lacking a specific treatment. Our study identified an anti-apoptosis role of CPCs-Ex in CVB3-infected cells and rats, which shown that CPCs-Ex may be an effective tool to treat viral myocarditis. We believe that with more in-depth research on the functionality of CPCs-Ex, there will be a breakthrough in the treatment of viral myocarditis.

DOI: 10.1038/s41419-019-1910-9
PubMed: 31534118
PubMed Central: PMC6751166


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Exosomes derived from cardiac progenitor cells attenuate CVB3-induced apoptosis via abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways.</title>
<author>
<name sortKey="Li, Xin" sort="Li, Xin" uniqKey="Li X" first="Xin" last="Li">Xin Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China. joyeelee@csu.edu.cn.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha</wicri:regionArea>
<wicri:noRegion>Changsha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yang, Zuocheng" sort="Yang, Zuocheng" uniqKey="Yang Z" first="Zuocheng" last="Yang">Zuocheng Yang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha</wicri:regionArea>
<wicri:noRegion>Changsha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nie, Wenyuan" sort="Nie, Wenyuan" uniqKey="Nie W" first="Wenyuan" last="Nie">Wenyuan Nie</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Urology, Chinese People's Liberation Army, 89th Hospital, Weifang, Shandong, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Urology, Chinese People's Liberation Army, 89th Hospital, Weifang, Shandong</wicri:regionArea>
<wicri:noRegion>Shandong</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jiang, Jie" sort="Jiang, Jie" uniqKey="Jiang J" first="Jie" last="Jiang">Jie Jiang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha</wicri:regionArea>
<wicri:noRegion>Changsha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Li, Shentang" sort="Li, Shentang" uniqKey="Li S" first="Shentang" last="Li">Shentang Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha</wicri:regionArea>
<wicri:noRegion>Changsha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Li, Zhuoying" sort="Li, Zhuoying" uniqKey="Li Z" first="Zhuoying" last="Li">Zhuoying Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha</wicri:regionArea>
<wicri:noRegion>Changsha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tian, Lang" sort="Tian, Lang" uniqKey="Tian L" first="Lang" last="Tian">Lang Tian</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha</wicri:regionArea>
<wicri:noRegion>Changsha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ma, Xing" sort="Ma, Xing" uniqKey="Ma X" first="Xing" last="Ma">Xing Ma</name>
<affiliation wicri:level="3">
<nlm:affiliation>Sate Key Laboratory of Advanced Welding and Joining, Harbin Institute of Technology (Shenzhen), Shenzhen, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sate Key Laboratory of Advanced Welding and Joining, Harbin Institute of Technology (Shenzhen), Shenzhen</wicri:regionArea>
<placeName>
<settlement type="city">Shenzhen</settlement>
<region type="province">Guangdong</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31534118</idno>
<idno type="pmid">31534118</idno>
<idno type="doi">10.1038/s41419-019-1910-9</idno>
<idno type="pmc">PMC6751166</idno>
<idno type="wicri:Area/Main/Corpus">000193</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000193</idno>
<idno type="wicri:Area/Main/Curation">000193</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000193</idno>
<idno type="wicri:Area/Main/Exploration">000193</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Exosomes derived from cardiac progenitor cells attenuate CVB3-induced apoptosis via abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways.</title>
<author>
<name sortKey="Li, Xin" sort="Li, Xin" uniqKey="Li X" first="Xin" last="Li">Xin Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China. joyeelee@csu.edu.cn.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha</wicri:regionArea>
<wicri:noRegion>Changsha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yang, Zuocheng" sort="Yang, Zuocheng" uniqKey="Yang Z" first="Zuocheng" last="Yang">Zuocheng Yang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha</wicri:regionArea>
<wicri:noRegion>Changsha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nie, Wenyuan" sort="Nie, Wenyuan" uniqKey="Nie W" first="Wenyuan" last="Nie">Wenyuan Nie</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Urology, Chinese People's Liberation Army, 89th Hospital, Weifang, Shandong, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Urology, Chinese People's Liberation Army, 89th Hospital, Weifang, Shandong</wicri:regionArea>
<wicri:noRegion>Shandong</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jiang, Jie" sort="Jiang, Jie" uniqKey="Jiang J" first="Jie" last="Jiang">Jie Jiang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha</wicri:regionArea>
<wicri:noRegion>Changsha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Li, Shentang" sort="Li, Shentang" uniqKey="Li S" first="Shentang" last="Li">Shentang Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha</wicri:regionArea>
<wicri:noRegion>Changsha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Li, Zhuoying" sort="Li, Zhuoying" uniqKey="Li Z" first="Zhuoying" last="Li">Zhuoying Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha</wicri:regionArea>
<wicri:noRegion>Changsha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tian, Lang" sort="Tian, Lang" uniqKey="Tian L" first="Lang" last="Tian">Lang Tian</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha</wicri:regionArea>
<wicri:noRegion>Changsha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ma, Xing" sort="Ma, Xing" uniqKey="Ma X" first="Xing" last="Ma">Xing Ma</name>
<affiliation wicri:level="3">
<nlm:affiliation>Sate Key Laboratory of Advanced Welding and Joining, Harbin Institute of Technology (Shenzhen), Shenzhen, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sate Key Laboratory of Advanced Welding and Joining, Harbin Institute of Technology (Shenzhen), Shenzhen</wicri:regionArea>
<placeName>
<settlement type="city">Shenzhen</settlement>
<region type="province">Guangdong</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Cell death & disease</title>
<idno type="eISSN">2041-4889</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Apoptosis (physiology)</term>
<term>Cell Line (MeSH)</term>
<term>Cell Proliferation (physiology)</term>
<term>Coxsackievirus Infections (metabolism)</term>
<term>Coxsackievirus Infections (pathology)</term>
<term>Coxsackievirus Infections (therapy)</term>
<term>Coxsackievirus Infections (virology)</term>
<term>Enterovirus B, Human (physiology)</term>
<term>Exosomes (metabolism)</term>
<term>Male (MeSH)</term>
<term>Myocarditis (metabolism)</term>
<term>Myocarditis (pathology)</term>
<term>Myocarditis (therapy)</term>
<term>Myocarditis (virology)</term>
<term>Myocardium (cytology)</term>
<term>Myocardium (metabolism)</term>
<term>Rats (MeSH)</term>
<term>Rats, Sprague-Dawley (MeSH)</term>
<term>Signal Transduction (MeSH)</term>
<term>Stem Cells (cytology)</term>
<term>Stem Cells (metabolism)</term>
<term>TOR Serine-Threonine Kinases (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux (MeSH)</term>
<term>Apoptose (physiologie)</term>
<term>Cellules souches (cytologie)</term>
<term>Cellules souches (métabolisme)</term>
<term>Entérovirus humain B (physiologie)</term>
<term>Exosomes (métabolisme)</term>
<term>Infections à virus coxsackie (anatomopathologie)</term>
<term>Infections à virus coxsackie (métabolisme)</term>
<term>Infections à virus coxsackie (thérapie)</term>
<term>Infections à virus coxsackie (virologie)</term>
<term>Lignée cellulaire (MeSH)</term>
<term>Myocarde (cytologie)</term>
<term>Myocarde (métabolisme)</term>
<term>Myocardite (anatomopathologie)</term>
<term>Myocardite (métabolisme)</term>
<term>Myocardite (thérapie)</term>
<term>Myocardite (virologie)</term>
<term>Mâle (MeSH)</term>
<term>Prolifération cellulaire (physiologie)</term>
<term>Rat Sprague-Dawley (MeSH)</term>
<term>Rats (MeSH)</term>
<term>Sérine-thréonine kinases TOR (métabolisme)</term>
<term>Transduction du signal (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>TOR Serine-Threonine Kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Infections à virus coxsackie</term>
<term>Myocardite</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr">
<term>Cellules souches</term>
<term>Myocarde</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Myocardium</term>
<term>Stem Cells</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Coxsackievirus Infections</term>
<term>Exosomes</term>
<term>Myocarditis</term>
<term>Myocardium</term>
<term>Stem Cells</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Cellules souches</term>
<term>Exosomes</term>
<term>Infections à virus coxsackie</term>
<term>Myocarde</term>
<term>Myocardite</term>
<term>Sérine-thréonine kinases TOR</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Coxsackievirus Infections</term>
<term>Myocarditis</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Apoptose</term>
<term>Entérovirus humain B</term>
<term>Prolifération cellulaire</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Apoptosis</term>
<term>Cell Proliferation</term>
<term>Enterovirus B, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Coxsackievirus Infections</term>
<term>Myocarditis</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr">
<term>Infections à virus coxsackie</term>
<term>Myocardite</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections à virus coxsackie</term>
<term>Myocardite</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Coxsackievirus Infections</term>
<term>Myocarditis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cell Line</term>
<term>Male</term>
<term>Rats</term>
<term>Rats, Sprague-Dawley</term>
<term>Signal Transduction</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Lignée cellulaire</term>
<term>Mâle</term>
<term>Rat Sprague-Dawley</term>
<term>Rats</term>
<term>Transduction du signal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Viral myocarditis is potentially fatal and lacking a specific treatment. Exosomes secreted by cardiac progenitor cells (CPCs) have emerged as a promising tool for cardioprotection and repair. In this study, we investigated whether CPCs-derived exosomes (CPCs-Ex) could utilize the mTOR signal pathway to reduce the apoptosis in viral myocarditis. In vitro, exosomes were, respectively, added to H9C2 cells after CVB3 infection to detect the anti-apoptosis effect of CPCs-Ex. Compared with the controls, the apoptosis rate was reduced, accompanied with the depressed expression of viral capsid protein 1 (VP1) and pro-apoptosis factors of Bim/caspase families. Meanwhile, the phosphorylation of Akt, mTOR, and p70S6K were promoted, but that of 4EBP1 was suppressed. In vivo, the results of apoptosis, expression of CVB3 and pro-apoptosis factors, and phosphorylation of Akt/mTOR factors of CVB3-infected cardiomyocytes were consistent with that of vitro. Following that, we use Rapamycin and MK-2206 to inhibit the Akt/mTOR signaling pathway, meanwhile, Rattus 4EBP1, p70S6K, Akt1 and Akt2 were transfected to H9C2 cells to establish the stably transfected cell lines. In the group with Rapamycin or MK-2206 pretreatment, CPCs-Ex also could decrease the apoptosis of H9C2 cells and expression of CVB3 mRNA, followed by decreased expression of apoptosis factors. In Akt2, p70S6K and 4EBP1 overexpression groups, CPCs-Ex promoted CVB3-induced apoptosis, VP1 expression and cleavage of caspase-3. Our results therefore identify CPCs-Ex exerts an anti-apoptosis effect in CVB3-infected cells by abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways as well as the expression of Bcl-2 and caspase families. Viral myocarditis, mainly caused by CVB3 infection, is lacking a specific treatment. Our study identified an anti-apoptosis role of CPCs-Ex in CVB3-infected cells and rats, which shown that CPCs-Ex may be an effective tool to treat viral myocarditis. We believe that with more in-depth research on the functionality of CPCs-Ex, there will be a breakthrough in the treatment of viral myocarditis.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">31534118</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>09</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>09</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">2041-4889</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>10</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2019</Year>
<Month>09</Month>
<Day>18</Day>
</PubDate>
</JournalIssue>
<Title>Cell death & disease</Title>
<ISOAbbreviation>Cell Death Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Exosomes derived from cardiac progenitor cells attenuate CVB3-induced apoptosis via abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways.</ArticleTitle>
<Pagination>
<MedlinePgn>691</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-019-1910-9</ELocationID>
<Abstract>
<AbstractText>Viral myocarditis is potentially fatal and lacking a specific treatment. Exosomes secreted by cardiac progenitor cells (CPCs) have emerged as a promising tool for cardioprotection and repair. In this study, we investigated whether CPCs-derived exosomes (CPCs-Ex) could utilize the mTOR signal pathway to reduce the apoptosis in viral myocarditis. In vitro, exosomes were, respectively, added to H9C2 cells after CVB3 infection to detect the anti-apoptosis effect of CPCs-Ex. Compared with the controls, the apoptosis rate was reduced, accompanied with the depressed expression of viral capsid protein 1 (VP1) and pro-apoptosis factors of Bim/caspase families. Meanwhile, the phosphorylation of Akt, mTOR, and p70S6K were promoted, but that of 4EBP1 was suppressed. In vivo, the results of apoptosis, expression of CVB3 and pro-apoptosis factors, and phosphorylation of Akt/mTOR factors of CVB3-infected cardiomyocytes were consistent with that of vitro. Following that, we use Rapamycin and MK-2206 to inhibit the Akt/mTOR signaling pathway, meanwhile, Rattus 4EBP1, p70S6K, Akt1 and Akt2 were transfected to H9C2 cells to establish the stably transfected cell lines. In the group with Rapamycin or MK-2206 pretreatment, CPCs-Ex also could decrease the apoptosis of H9C2 cells and expression of CVB3 mRNA, followed by decreased expression of apoptosis factors. In Akt2, p70S6K and 4EBP1 overexpression groups, CPCs-Ex promoted CVB3-induced apoptosis, VP1 expression and cleavage of caspase-3. Our results therefore identify CPCs-Ex exerts an anti-apoptosis effect in CVB3-infected cells by abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways as well as the expression of Bcl-2 and caspase families. Viral myocarditis, mainly caused by CVB3 infection, is lacking a specific treatment. Our study identified an anti-apoptosis role of CPCs-Ex in CVB3-infected cells and rats, which shown that CPCs-Ex may be an effective tool to treat viral myocarditis. We believe that with more in-depth research on the functionality of CPCs-Ex, there will be a breakthrough in the treatment of viral myocarditis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Xin</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China. joyeelee@csu.edu.cn.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Zuocheng</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nie</LastName>
<ForeName>Wenyuan</ForeName>
<Initials>W</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-6532-7237</Identifier>
<AffiliationInfo>
<Affiliation>Department of Urology, Chinese People's Liberation Army, 89th Hospital, Weifang, Shandong, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jiang</LastName>
<ForeName>Jie</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Shentang</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Zhuoying</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tian</LastName>
<ForeName>Lang</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ma</LastName>
<ForeName>Xing</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Sate Key Laboratory of Advanced Welding and Joining, Harbin Institute of Technology (Shenzhen), Shenzhen, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>09</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Cell Death Dis</MedlineTA>
<NlmUniqueID>101524092</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="C546845">mTOR protein, rat</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055354" MajorTopicYN="N">Exosomes</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009205" MajorTopicYN="N">Myocarditis</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2019</Year>
<Month>04</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2019</Year>
<Month>08</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2019</Year>
<Month>08</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>9</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>9</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>9</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31534118</ArticleId>
<ArticleId IdType="doi">10.1038/s41419-019-1910-9</ArticleId>
<ArticleId IdType="pii">10.1038/s41419-019-1910-9</ArticleId>
<ArticleId IdType="pmc">PMC6751166</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
<region>
<li>Guangdong</li>
</region>
<settlement>
<li>Shenzhen</li>
</settlement>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Li, Xin" sort="Li, Xin" uniqKey="Li X" first="Xin" last="Li">Xin Li</name>
</noRegion>
<name sortKey="Jiang, Jie" sort="Jiang, Jie" uniqKey="Jiang J" first="Jie" last="Jiang">Jie Jiang</name>
<name sortKey="Li, Shentang" sort="Li, Shentang" uniqKey="Li S" first="Shentang" last="Li">Shentang Li</name>
<name sortKey="Li, Zhuoying" sort="Li, Zhuoying" uniqKey="Li Z" first="Zhuoying" last="Li">Zhuoying Li</name>
<name sortKey="Ma, Xing" sort="Ma, Xing" uniqKey="Ma X" first="Xing" last="Ma">Xing Ma</name>
<name sortKey="Nie, Wenyuan" sort="Nie, Wenyuan" uniqKey="Nie W" first="Wenyuan" last="Nie">Wenyuan Nie</name>
<name sortKey="Tian, Lang" sort="Tian, Lang" uniqKey="Tian L" first="Lang" last="Tian">Lang Tian</name>
<name sortKey="Yang, Zuocheng" sort="Yang, Zuocheng" uniqKey="Yang Z" first="Zuocheng" last="Yang">Zuocheng Yang</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000343 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000343 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31534118
   |texte=   Exosomes derived from cardiac progenitor cells attenuate CVB3-induced apoptosis via abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31534118" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020